首页> 美国卫生研究院文献>Biochemistry Insights >Effects of Sterculia setigera Del. Stem Bark Extract on Hematological and Biochemical Parameters of Wistar Rats
【2h】

Effects of Sterculia setigera Del. Stem Bark Extract on Hematological and Biochemical Parameters of Wistar Rats

机译:三角菊干茎皮提取物对Wistar大鼠血液学和生化指标的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Africa is rich in a wide range of flora that are exploited as herbal medicines and remedies. Several diseases such as diabetes, diarrhea, dysentery and jaundice have been successfully managed using herbal medicines. Herbal decoctions or concoctions have been used as pain killers, antibiotics, and hematinics. This study evaluated the hematopoietic and biochemical properties of the stem bark of Sterculia setigera Del. in Wistar rats. Results showed that S. setigera decoction has copiously high tannin and cardiac glycoside levels. Ingestion of the decoction by rats over a 16-day period significantly (P < 0.05) increased the body weights of rats by 22.4% in the S. setigera-treated group. Hematological profiles showed raised levels of red blood cells, hemoglobin, packed cell volume, mean corpuscular volume, mean cell hemoglobin, mean cell hemoglobin concentration, and platelets, while biochemical parameters showed lower levels of alanine aminotransferase and aspartate aminotransferase, and slight increase in albumin and TP levels. We posit that the results justify the use of the stem bark of S. setigera as a hematinic by traditional medical practitioners and show its relative safety. Further experiments are needed to evaluate its safety.
机译:非洲拥有丰富的植物区系,这些植物被用作草药和药物。使用草药已成功治疗了多种疾病,例如糖尿病,腹泻,痢疾和黄疸。草药汤或药汤已被用作止痛药,抗生素和造血药。这项研究评估了Wistar大鼠中Sterculia setigera Del。茎皮的造血和生化特性。结果表明,S。setigera汤具有很高的单宁和强心苷水平。在S. setigera治疗组中,大鼠在16天的时间内摄入水煎可显着增加(P <0.05)大鼠的体重22.4%。血液学特征显示血红蛋白,血红蛋白,堆积细胞体积,平均红细胞体积,平均细胞血红蛋白,平均细胞血红蛋白浓度和血小板水平升高,而生化参数显示丙氨酸氨基转移酶和天冬氨酸氨基转移酶水平较低,白蛋白略有增加和TP水平。我们认为,该结果证明了传统医学从业人员使用Setigera Sigera的茎皮作为血凝素是合理的,并证明了其相对安全性。需要进一步的实验来评估其安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号